BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) Operating cash flow 2017–2025
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$65,150FY2025 · since FY2017: -$25,898 → -$65,150
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65,150 | -6.4% |
| FY2024 | -$61,250 | -31.2% |
| FY2023 | -$46,702 | +31.7% |
| FY2022 | -$68,389 | +12.1% |
| FY2021 | -$77,772 | +3.0% |
| FY2020 | -$80,196 | -228.9% |
| FY2019 | -$24,383 | +61.0% |
| FY2018 | -$62,466 | -141.2% |
| FY2017 | -$25,898 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BFNH financial trends
BFNH RevenueBFNH Net incomeBFNH Net marginBFNH Gross profitBFNH Gross marginBFNH Operating incomeBFNH Operating marginBFNH Free cash flowBFNH Capital expendituresBFNH Return on equityBFNH Stock buybacksBFNH Dividends paidBFNH Total assetsBFNH Total liabilitiesBFNH Shareholders’ equityBFNH overview →